clinical trial · NCT00092560
Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)
Organon and Co·phase3·completed·n = 587
HypercholesterolemiaHypertriglyceridemiaMK0653, ezetimibeComparator: fenofibrate monotherapy
brief summary
The purpose of this study is to evaluate the cholesterol lowering effectiveness and safety of two investigational drugs in patients with mixed hyperlipidemia (high cholesterol and high triglycerides).
started
Dec 1, 2002
primary completion
Dec 1, 2003
completion
Dec 1, 2003
last updated
Aug 15, 2024
detailed description
The duration of treatment is 18 weeks.
official title
Evaluation of the Efficacy and Safety of Fenofibrate and Ezetimibe Coadministration in Patients With Mixed Hyperlipidemia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol